Sep 20, 2016 at 11:56 | Source: Moneycontrol.com
The agreement includes early stage development to the final commercialisation of the vaccine.
Sep 07, 2016 at 11:32 | Source: CNBC-TV18
The company is focusing on vaccinations for dengue and pneumonia solutions and sending them to Asian & African countries, said Adar Poonawalla,CEO & Executive Director, Serum Institute of India.
Aug 24, 2016 at 14:33 | Source: CNBC-TV18
In earnings' conference call, Jhunjhunwala who currently holds 1.12 percent stake in the company threw a volley of questions to the management. The big bull raised questions on Aurobindo Pharma's finance cost, capex, rationale behind investment in vaccines, product launch, potential revenue growth and its fund raising plans.
Aug 23, 2016 at 19:40 | Source: PTI
Chennai-based GreenSignal Bio Pharma is likely to come out with an Initial Public Offer (IPO) in October to raise around Rs 100 crore.
Aug 15, 2016 at 17:30 | Source: PTI
Vaccines segment is another addition to the company's differentiated portfolio where there are unmet needs and limited competition, Aurobindo Pharma said in its annual report.
Jul 29, 2016 at 15:10 | Source: CNBC-TV18
Twenty three percent revenue run rate is sustainable for the full year, said Rajiv Gandhi, CEO & MD of Hester Biosciences.
Jun 24, 2016 at 06:44 | Source: PTI
Nadda was speaking after reviewing the special immunisation drive undertaken in Hyderabad and Ranga Reddy districts in the wake of VDPV being found here, with state Health Minister C Laxma Reddy and officials.
Jun 15, 2016 at 22:08 | Source: PTI
"The campaign, to be conducted from June 20 to 26, would be carried out at 700 booths," said Lalitha Kumari, Director of Public Health and Family Welfare.
Jun 15, 2016 at 17:00 | Source: PTI
Amidst concerns over wild polio virus (P2 strain) being found in a Hyderabad drain, the Union Health Ministry said it was a vaccine derived virus and does not change the polio-free status of India
May 25, 2016 at 21:22 | Source: PTI
Biotechnology major Biocon has proposed an investment of Rs 1,060 crore for the manufacture of injectables, monoclonal and anti-bodies vaccine at Anekal taluk. It is expected to employ about 750 people, an official release said.